To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Tiny tool can play big role against tuberculosis
21-05-2012: A tiny filter could have a big impact around the world in the fight against tuberculosis. Using the traditional microscope-based diagnosis method as a starting point, a University of Florida lung disease specialist and colleagues in Brazil have devised a way to detect more cases of the bacterial infection.
“We’re hopeful that this more sensitive method, which is both simple and inexpensive, will improve diagnosis in patients,” said lead researcher Kevin Fennelly, M.D., M.P.H., an associate professor in the UF College of Medicine’s department of medicine and Southeastern Tuberculosis Center, and the UF Emerging Pathogens Institute.
The new technique, which involves vacuum filtering a sputum sample treated with household bleach and other simple chemicals through a small filter, could dramatically improve TB diagnoses globally, particularly in settings where the disease is common and resources are limited. It is especially useful when the presence of only a small number of bacteria in the test sample makes it hard to detect TB. The researchers are refining the technique in hopes of developing a cost-effective product that can be used globally.
Funded by the World Health Organization and the Núcleo de Doenças Infecciosas infectious disease institute in Brazil, the study appears online and in an upcoming print edition of the Journal of Clinical Microbiology.
“TB is still a tremendously important disease worldwide and control efforts are greatly hindered by lack of simple, inexpensive diagnostics that could be used at the point of care,” said Elizabeth Talbot, M.D., a Dartmouth College infectious diseases and TB diagnostics expert who was not involved in the UF research. “What Dr. Fennelly has done is capitalize on existing infrastructure of microscopy to try to improve performance of that prevalent diagnostic tool.”
The most widely used way to confirm TB infection is to use a microscope to identify and count disease-causing bacteria in sputum smeared onto a glass slide. This so-called direct-smear method also helps health professionals figure out how likely people are to pass on the disease, what treatment decisions should be made, and how well patients are responding to treatment. Although the method has been in continuous use for more than a century, it can be unreliable, catching cases only about half of the time, on average.
Part of the problem is that sometimes sputum samples don’t contain many bacteria, making it hard to detect TB. Concentrating bacteria onto a small area could help improve detection accuracy, and although previous efforts have led to improvements, they tend to require expensive equipment or technical know-how. In some cases, gains were offset by loss of sample or safety concerns. So the quest for a low-cost, simple, effective method led back to the trusty microscope.
In the early 1980s researchers vacuum-filtered sputum samples to trap TB bacteria onto quarter-sized filters that were then viewed under a microscope. But the filters hung over the sides of standard microscope slides, posing a health hazard and preventing proper inspection. So Fennelly and his team decided to try smaller-than-a-dime filters that fit neatly onto microscope slides and that concentrated the bacteria even more.
Among 314 patients in Brazil suspected as having TB, but not yet in treatment, the small-filter method detected 89 percent of cases, compared with 60 percent detection when samples were concentrated by the currently used method of rapid spinning, and 56 percent detection when sputum smears were looked at directly under the microscope. Furthermore, the small-filter method identified almost three-quarters of TB-positive cases that had been incorrectly reported as negative based on the traditional technique.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
- 1Pro Bono Bio Launches Flexiseq: A Novel Approach to the Treatment of Osteoarthritis
- 2Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 3Vivacta Initiates Development of Point of Care Test for Vitamin D
- 4Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 5Researchers divide enzyme to conquer genetic puzzle
- 6A light switch inside the brain
- 7Merck & Co., Inc. Opens Asia Pacific Regional Headquarters in Singapore
- 8Pharmexa A/S sells Pharmexa-Epimmune to the Korean company VaxOnco, Inc.
- 9New study confirms fungal infection of the foot is a risk factor for bacterial tissue infection of the leg
- 10MIV-210 - a potential drug against hepatitis B and HIV - enters phase II
